Insight Molecular Diagnostics Inc. Common Stock IMDX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$4.29M+81.3% | -$22.96M-111% | -$10.85M-11.4% | -$9.74M-46.0% | -$6.67M+80.1% | ||
| $631K+12.1% | $563K-3.6% | $584K+4.5% | $559K+15.5% | $484K-10.5% | ||
| $615K-14.7% | $721K+38.4% | $521K+3.4% | $504K+6.6% | $473K-5.2% | ||
| -$7.64M-37.8% | -$5.55M-23.2% | -$4.5M+28.5% | -$6.3M-7.9% | -$5.84M-9.1% | ||
| $613K-58.6% | $1.48M+40.9% | $1.05M+201% | $349K+13.7% | $307K+43.5% | ||
| -$613K+58.6% | -$1.48M-40.9% | -$1.05M-201% | -$349K-13.7% | -$307K-46.2% | ||
| $24.7M— | —— | —— | —— | $28.56M+164% | ||
| $16.44M— | —— | —— | —— | $22.39M— | ||
| -$8.25M-17.5% | -$7.02M-26.5% | -$5.55M+16.5% | -$6.65M-8.2% | -$6.15M-10.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Insight Molecular Diagnostics Inc. Common Stock generate?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) generated -$24.0M in operating cash flow over the trailing twelve months.
- What is Insight Molecular Diagnostics Inc. Common Stock's free cash flow?
- After $3.5M of capital expenditures, Insight Molecular Diagnostics Inc. Common Stock's free cash flow was -$27.5M over the trailing twelve months, down 16.9% year over year.
- Where does Insight Molecular Diagnostics Inc. Common Stock's cash flow data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
